These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids. Spiecker M; Liao JK Arch Biochem Biophys; 2005 Jan; 433(2):413-20. PubMed ID: 15581597 [TBL] [Abstract][Full Text] [Related]
23. Cytochrome P450 metabolites of arachidonic acid: rapid incorporation and hydration of 14,15-epoxyeicosatrienoic acid in arterial smooth muscle cells. Fang X; Kaduce TL; Weintraub NL; Spector AA Prostaglandins Leukot Essent Fatty Acids; 1997 Oct; 57(4-5):367-71. PubMed ID: 9430380 [TBL] [Abstract][Full Text] [Related]
24. Cyp2c44 epoxygenase-derived epoxyeicosatrienoic acids in vascular smooth muscle cells elicit vasoconstriction of the murine ophthalmic artery. Hu J; Sisignano M; Brecht R; Perumal N; Angioni C; Bibli IS; Fisslthaler B; Kleinert H; Pfeiffer N; Fleming I; Manicam C Sci Rep; 2021 Sep; 11(1):18764. PubMed ID: 34548575 [TBL] [Abstract][Full Text] [Related]
25. 5,6-epoxyeicosatrienoic acid mediates the enhanced renal vasodilation to arachidonic acid in the SHR. Pomposiello SI; Quilley J; Carroll MA; Falck JR; McGiff JC Hypertension; 2003 Oct; 42(4):548-54. PubMed ID: 12939232 [TBL] [Abstract][Full Text] [Related]
26. Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation. Behm DJ; Ogbonna A; Wu C; Burns-Kurtis CL; Douglas SA J Pharmacol Exp Ther; 2009 Jan; 328(1):231-9. PubMed ID: 18836067 [TBL] [Abstract][Full Text] [Related]
27. 20-125Iodo-14,15-epoxyeicosa-5(Z)-enoic acid: a high-affinity radioligand used to characterize the epoxyeicosatrienoic acid antagonist binding site. Chen Y; Falck JR; Tuniki VR; Campbell WB J Pharmacol Exp Ther; 2009 Dec; 331(3):1137-45. PubMed ID: 19762546 [TBL] [Abstract][Full Text] [Related]
28. EETs Elicit Direct Increases in Pulmonary Arterial Pressure in Mice. Kandhi S; Froogh G; Qin J; Luo M; Wolin MS; Huang A; Sun D Am J Hypertens; 2016 May; 29(5):598-604. PubMed ID: 26304959 [TBL] [Abstract][Full Text] [Related]
29. EETs and CYP2J2 inhibit TNF-α-induced apoptosis in pulmonary artery endothelial cells and TGF-β1-induced migration in pulmonary artery smooth muscle cells. Feng W; Xu X; Zhao G; Li G; Liu T; Zhao J; Dong R; Wang DW; Tu L Int J Mol Med; 2013 Sep; 32(3):685-93. PubMed ID: 23835530 [TBL] [Abstract][Full Text] [Related]
30. 14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries. Gauthier KM; Falck JR; Reddy LM; Campbell WB Pharmacol Res; 2004 Jun; 49(6):515-24. PubMed ID: 15026029 [TBL] [Abstract][Full Text] [Related]
31. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. Oltman CL; Weintraub NL; VanRollins M; Dellsperger KC Circ Res; 1998 Nov; 83(9):932-9. PubMed ID: 9797342 [TBL] [Abstract][Full Text] [Related]
32. Characterization of 14,15-epoxyeicosatrienoyl-sulfonamides as 14,15-epoxyeicosatrienoic acid agonists: use for studies of metabolism and ligand binding. Yang W; Holmes BB; Gopal VR; Kishore RV; Sangras B; Yi XY; Falck JR; Campbell WB J Pharmacol Exp Ther; 2007 Jun; 321(3):1023-31. PubMed ID: 17327488 [TBL] [Abstract][Full Text] [Related]
33. Regulation of potassium channels in coronary smooth muscle by adenoviral expression of cytochrome P-450 epoxygenase. Campbell WB; Holmes BB; Falck JR; Capdevila JH; Gauthier KM Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H64-71. PubMed ID: 16143653 [TBL] [Abstract][Full Text] [Related]
34. Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury. Nithipatikom K; Moore JM; Isbell MA; Falck JR; Gross GJ Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H537-42. PubMed ID: 16473964 [TBL] [Abstract][Full Text] [Related]
35. Hypoxic pulmonary vasoconstriction in isolated rat pulmonary arteries is not inhibited by antagonists of H2 S-synthesizing pathways. Prieto-Lloret J; Shaifta Y; Ward JP; Aaronson PI J Physiol; 2015 Jan; 593(2):385-401. PubMed ID: 25630260 [TBL] [Abstract][Full Text] [Related]
36. High potassium intake enhances the inhibitory effect of 11,12-EET on ENaC. Sun P; Lin DH; Yue P; Jiang H; Gotlinger KH; Schwartzman ML; Falck JR; Goli M; Wang WH J Am Soc Nephrol; 2010 Oct; 21(10):1667-77. PubMed ID: 20595684 [TBL] [Abstract][Full Text] [Related]
37. Epoxyeicosatrienoic acids mediate adenosine-induced vasodilation in rat preglomerular microvessels (PGMV) via A2A receptors. Cheng MK; Doumad AB; Jiang H; Falck JR; McGiff JC; Carroll MA Br J Pharmacol; 2004 Feb; 141(3):441-8. PubMed ID: 14718251 [TBL] [Abstract][Full Text] [Related]
38. Involvement of gap junctions between smooth muscle cells in sustained hypoxic pulmonary vasoconstriction development: a potential role for 15-HETE and 20-HETE. Kizub IV; Lakhkar A; Dhagia V; Joshi SR; Jiang H; Wolin MS; Falck JR; Koduru SR; Errabelli R; Jacobs ER; Schwartzman ML; Gupte SA Am J Physiol Lung Cell Mol Physiol; 2016 Apr; 310(8):L772-83. PubMed ID: 26895643 [TBL] [Abstract][Full Text] [Related]
39. Differential effect of amyloid β on the cytochrome P450 epoxygenase activity in rat brain. Sarkar P; Narayanan J; Harder DR Neuroscience; 2011 Oct; 194():241-9. PubMed ID: 21843605 [TBL] [Abstract][Full Text] [Related]
40. Effects of mitochondrial inhibitors and uncouplers on hypoxic vasoconstriction in rabbit lungs. Weissmann N; Ebert N; Ahrens M; Ghofrani HA; Schermuly RT; Hänze J; Fink L; Rose F; Conzen J; Seeger W; Grimminger F Am J Respir Cell Mol Biol; 2003 Dec; 29(6):721-32. PubMed ID: 12791676 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]